Clinical trial
Duodenal Exclusion for the Treatment of T2DM
NCT00456352 · Medtronic - MITG, Industry · Completed
Key facts
| NCT number | NCT00456352 |
|---|---|
| Title | Duodenal Exclusion for the Treatment of T2DM |
| Official title | Phase IV Study of Duodenal Exclusion for the Treatment of Type 2 Diabetes Mellitus (T2DM) |
| Lead sponsor | Medtronic - MITG, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes |
| Intervention type | Procedure |
| Interventions | duodenal exclusion |
| Enrollment | 37 |
| Start date | Apr 1, 2007 |
| Primary completion | Apr 1, 2009 |
| Completion | Oct 1, 2010 |
| First posted | Apr 4, 2007 |
| Last update posted | Aug 22, 2014 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: